Viatris: Number of Employees 2010-2025 | VTRS

Interactive chart of Viatris (VTRS) annual worldwide employee count from 2010 to 2025.
  • Viatris total number of employees in 2024 was 32,000, a 15.79% decline from 2023.
  • Viatris total number of employees in 2023 was 38,000, a 2.7% increase from 2022.
  • Viatris total number of employees in 2022 was 37,000, a 0% decline from 2021.
  • Viatris total number of employees in 2021 was 37,000, a 17.78% decline from 2020.
Viatris Annual Employee Count
2024 32,000
2023 38,000
2022 37,000
2021 37,000
2020 45,000
2019 35,000
2018 35,000
2017 35,000
2016 35,000
2015 35,000
2014 30,000
2013 20,000
2012 20,000
2011 18,000
2010 13,000
2009 15,500
Sector Industry Market Cap Revenue
Medical Medical Services $10.704B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.605B 27.50
CVS Health (CVS) United States $81.948B 10.19
Elevance Health (ELV) United States $76.969B 9.93
Cencora (COR) United States $57.218B 19.91
DiDi Global (DIDIY) China $24.191B 25.70
Natera (NTRA) United States $21.906B 0.00
Labcorp Holdings (LH) United States $20.893B 16.95
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.687B 0.00
CochLear (CHEOY) Australia $12.827B 0.00
Solventum (SOLV) United States $12.768B 13.52
ICON (ICLR) Ireland $12.156B 11.30
Revvity (RVTY) United States $11.964B 20.59
Medpace Holdings (MEDP) United States $9.298B 24.69
Avantor (AVTR) United States $9.254B 13.45
Sonic Healthcare (SKHHY) Australia $8.638B 0.00
HealthEquity (HQY) United States $8.174B 35.80
Charles River Laboratories (CRL) United States $7.829B 15.34
Caris Life Sciences,�Inc (CAI) United States $6.744B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.911B 28.92
BrightSpring Health Services (BTSG) United States $3.571B 32.76
Sotera Health (SHC) United States $3.349B 19.03
Surgery Partners (SGRY) United States $2.825B 36.73
Alignment Healthcare (ALHC) United States $2.645B 0.00
Organon (OGN) United States $2.584B 2.75
Concentras Parent (CON) United States $2.551B 14.74
GeneDx Holdings (WGS) United States $2.356B 90.73
Ardent Health (ARDT) United States $2.027B 8.64
Progyny (PGNY) United States $1.990B 43.79
PACS (PACS) United States $1.932B 0.00
Premier (PINC) United States $1.736B 13.18
GoodRx Holdings (GDRX) United States $1.695B 33.89
Teladoc Health (TDOC) United States $1.460B 0.00
Establishment Labs Holdings (ESTA) $1.298B 0.00
Pediatrix Medical (MD) United States $1.127B 8.58
CareDx (CDNA) United States $1.121B 17.50
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.923B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.810B 7.58
Nutex Health (NUTX) United States $0.637B 9.64
Embecta (EMBC) United States $0.612B 4.12
InnovAge Holding (INNV) United States $0.559B 0.00
SBC Medicals (SBC) United States $0.523B 0.00
LifeMD (LFMD) United States $0.512B 0.00
Sonida Senior Living (SNDA) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
Omada Health (OMDA) $0.455B 0.00
So-Young (SY) China $0.390B 0.00
Enhabit (EHAB) United States $0.357B 29.38
COMPASS Pathways (CMPS) United Kingdom $0.344B 0.00
Performant Healthcare (PHLT) United States $0.321B 0.00
Oncology Institute (TOI) United States $0.279B 0.00
Beauty Health (SKIN) United States $0.241B 0.00
DocGo (DCGO) United States $0.152B 24.83
Pheton Holdings (PTHL) China $0.138B 0.00
Sera Prognostics (SERA) United States $0.107B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.074B 0.00
IceCure Medical (ICCM) Israel $0.061B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.046B 0.00
Biodesix (BDSX) United States $0.045B 0.00
Basel Medical Group (BMGL) Singapore $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
OSR Holdings (OSRH) United States $0.023B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00